Innovative Industrial Properties

Growing cannabis legally in America requires a building — a warehouse with industrial power, climate control, filtration and security. Building one costs tens of millions of dollars. And because cannabis remains illegal under federal law, the ordinary banking system will not finance it. No mortgage, no construction loan, no normal landlord.

Innovative Industrial Properties was built to stand in that gap. It buys the cultivation facility from the cannabis operator for cash, and immediately leases it back on a very long triple-net lease. The operator gets capital it cannot raise anywhere else and redeploys it into the business. IIPR gets a building and a rent cheque — at yields no ordinary industrial landlord could dream of, because it is one of very few parties willing to be there at all.

That is not a moat. It is a licence to lend where nobody else will. And the return is not a reward for skill — it is compensation for a risk the banking system has been forbidden to take.

For a while it worked magnificently. IIPR went public in December 2016, and by November 2021 the shares had reached $288.02. They are $55.99 today.

Below is every state where IIPR owns property, drawn from the geographic table in its annual report as at 31 December 2025. The shading is the share of rent actually collected during 2025 — not square footage, and not the number of buildings, because those three measures tell very different stories about this portfolio.

Three things in that picture matter more than the rest.

The concentration is severe. Five states — Pennsylvania, Florida, Illinois, Massachusetts and Michigan — produce 61% of all the rent. Pennsylvania alone is 15%.

Colorado is a trap for the unwary. It has 26 properties, more than any other state — and produces 3% of the rent. Those are dispensaries averaging under 9,000 square feet each. Across the whole portfolio, 33 of the 111 properties are retail shops generating just 3% of income, while 68 industrial cultivation buildings generate 90%. Anyone counting buildings to size this business will get it badly wrong.

★ And then there is Washington: one building, 114,000 square feet, $17.5 million invested — and zero rent collected in 2025. It is the only tile on the map in red, and it is what a defaulted cannabis property looks like on a balance sheet.

As at 31 December 2025, from the company's annual report. Square footage includes 303,000 square feet under development or redevelopment. Invested capital includes committed improvement allowances not yet funded. ⚠️ One of the ten Massachusetts "properties" is accounted for as a loan rather than owned real estate. ⚠️ By 30 June 2026 the portfolio had fallen to 108 properties.

This is the piece of tax law that explains almost everything about why IIPR's tenants cannot pay, and most coverage skips it.

Section 280E of the US tax code forbids any business "trafficking" in a Schedule I or II controlled substance from deducting ordinary business expenses. Not rent, not wages, not marketing, not utilities. A legal, state-licensed cannabis company must pay federal tax on something close to its gross profit rather than its actual profit.

The practical effect is that a cannabis operator can be profitable on paper and still run out of cash, because its effective tax rate can exceed 70%. Combine that with falling wholesale prices, competition from an untaxed illicit market, and no access to bank credit, and you have an industry structurally incapable of comfortably paying the rents IIPR charges. IIPR's rent is senior to the tenant's tax bill in commercial logic but junior to it in practice — the government gets paid first.

IIPR's annual report contains a sentence that should stop any income investor, and we are going to quote it exactly as written, because a paraphrase would soften it:

"For some or all of 2026, we expect that many tenants will continue to incur losses and may rely on cash on hand or asset sale proceeds, rather than operating cash flows, to fund rent payments." — IIPR annual report for the year ended 31 December 2025

That is a landlord telling you its tenants are paying the rent out of savings and by selling things. The same document states plainly that industry conditions "have already adversely affected certain tenants' ability to meet their lease obligations and have had a material adverse effect on our financial condition, results of operations, and cash flows."

Here is what that looks like in practice.

Add it up. PharmaCann was roughly 9.9% of annualised rent. The three tenants declared in default under the March 2025 initiative were about 11.6%. Add the smaller defaults and now Parallel, and something close to a quarter of this REIT's rent roll has been in default within eighteen months.

★ And notice what IIPR did in March 2025, because it is genuinely unusual. It did not wait for tenants to fail — it declared defaults deliberately, describing it as "a strategic initiative aimed at improving long-term financial performance by seeking to refresh a substantial portion of its tenant base with more financially viable, long-term tenants." A landlord evicting a quarter of its own rent roll on purpose is either admirably decisive or an admission that the original underwriting was wrong. We lean towards the first — you cannot fix this by waiting — but it is both.

The concentration makes it worse. The top ten tenants account for 75% of the rent across 64 of the 111 properties. When one of ten fails, it is not a rounding error.

IIPR has signed new leases on about 389,000 square feet across five properties so far this year. The Michigan property PharmaCann abandoned was re-let to a new operator within months, and the Massachusetts one found a third-party tenant. These buildings are not worthless — several have been successfully re-tenanted.

But be careful with the occupancy figure, because it is moving and it flatters. The operating portfolio was 95.8% leased at 30 June 2026, down from 98.6% a year earlier, and the weighted-average remaining lease term fell from 12.8 to 11.9 years in six months. More concretely: fourteen properties are now entirely vacant and one more is half-let — about 468,000 square feet standing empty, of which a single Pennsylvania building at Saxton accounts for 270,000. And "leased" counts a lease signed with a tenant in receivership as occupancy, which is exactly why we have used rent collected rather than occupancy throughout this report.

★ Two further details from the filings that sharpen the picture. Roughly $72 million of unpaid rent is owed by defaulted tenants, and about a quarter of annualised base rent sits with tenants that have been declared in default — PharmaCann 8.2%, Parallel 6.1%, Cannabist 6.0% and 4Front 5.6%. And PharmaCann still physically occupies the New York and Pennsylvania properties past their surrender dates, with IIPR's consent — which matters because that New York asset is the single largest property in the entire portfolio, at 5.7% of net real estate.

Our house rule is that any dividend-paying company gets its payout examined properly. For a REIT the correct measure is adjusted funds from operations — AFFO — which strips out the depreciation that makes a property company's earnings meaningless and reflects the cash actually available to distribute.

Here is the June 2026 quarter, and it is the whole report in two numbers.

So: is the dividend safe? We are going to answer that plainly rather than hedge it. No. Not at this level.

A REIT is legally obliged to distribute most of its taxable income, so it cannot simply stop paying. But it can and does reset the rate, and the arithmetic here points one way. The payout has exceeded AFFO for at least a quarter; AFFO per share is falling as defaults compound; revenue is down 14% from its peak and still declining; and a further default landed in Florida in the June quarter. Either rent collection recovers quickly, or the dividend comes down.

A 13.6% yield is not a reward the market has left lying on the table. It is the market's estimate of the probability that the number is wrong.

What genuinely protects this company is not the dividend — it is the balance sheet. Total debt is only about $394 million against $2.4 billion of assets: roughly 14% of gross assets and 1.7 times EBITDA. For a REIT that is exceptionally conservative; most carry five or six times. IIPR has the capacity to absorb a great deal of pain before anything existential happens. That is the single best thing about this investment, and it is why the shares are a distressed-yield situation rather than a solvency one.

⚠️ But the quality of that debt changed this year, and it is worth knowing. In the June 2026 quarter IIPR retired its 5.50% unsecured notes and replaced them with 6.00% exchangeable notes plus $221 million of senior secured term debt at rates of up to 9.00%. The leverage ratio is still low. But a company that used to borrow unsecured at five and a half percent now pledges buildings to borrow at nine. The amount of debt is not the problem; the price and the security package tell you what lenders now think of the collateral.

★ One more signal worth reading. IIPR built itself by issuing shares — over $1 billion of stock in 2020 alone, recycled into buildings at yields far above the cost of the equity. That machine has stopped: it raised just $24 million last year. And in 2025 it did something it had never done before — it bought back $20 million of its own stock. A growth REIT that starts repurchasing shares instead of issuing them is telling you it can no longer find deals worth doing at prices it can raise capital at. The growth model is over, and management has conceded it in the cash flow statement.

Every cannabis investor has spent years waiting for the federal government to move marijuana off Schedule I, the most restrictive category, where it sits alongside heroin. In April 2026, part of that finally happened — and almost nobody has thought through what it means for IIPR specifically.

Now the part that requires genuine thought, because the intuition is backwards.

The whole reason IIPR earns outsized yields is that banks are not allowed to compete with it. Its tenants pay above-market rent because IIPR is one of the only sources of capital willing to operate in a federally illegal industry. That is the entire economic engine.

★ Full rescheduling would rescue IIPR's tenants and destroy IIPR's business model at the same time. The catalyst everyone is waiting for is the thing that lets a normal bank offer the same operator a mortgage at half the cost.

So the ideal outcome for an IIPR shareholder is uncomfortably specific: enough reform that tenants stop going bankrupt, but not so much that ordinary lenders arrive. April's half-measure — medical relieved, recreational not — is arguably close to that. But it is a knife-edge, and it is not a position anyone would design on purpose.

The honest framing is this. If reform stalls, IIPR keeps its pricing power and keeps watching tenants fail. If reform completes, the tenants recover and IIPR's rents get refinanced away over the following years as leases expire or are renegotiated. There is no version of the future in which IIPR simply goes back to 2021.

Buried in the annual report is a sentence explaining a strategic change that has had almost no attention, and it tells you what management actually thinks about its own market:

"In light of these industry conditions and their impact on our existing portfolio, we have expanded our growth strategy to include a broader range of real estate and real estate-related investments." — IIPR annual report, FY2025

What that means in practice: IIPR has committed $270 million — roughly a sixth of its entire market capitalisation — to IQHQ, a private life-science real estate company that has nothing whatsoever to do with cannabis. As of 30 June 2026 the whole commitment is funded: $170 million of preferred stock and a $100 million share of IQHQ's credit facility.

The bull case is not stupid, and it goes like this. You are buying $2.5 billion of real buildings for $1.6 billion, at 0.86 times book, from a company with almost no debt, an 11.9-year average lease term, and a management team that built and sold a specialised REIT once before. The industry's tax burden has just been partly lifted. If rent collection stabilises anywhere near current levels, the shares are worth considerably more than this.

The bear case is simpler. Rent is falling, a quarter of the rent roll has defaulted, the dividend is not covered, the buildings are purpose-built for an industry with too much capacity, and the only catalyst that fixes the tenants also removes the reason the landlord earns outsized returns.

★ Our reading: the market is roughly right, and that is the uncomfortable conclusion. At $56 the shares appear to price a dividend rebase to something like $5 a year — which would still be a yield near 9%. The DCF says $56.53. The median analyst says $60. This is not obviously mispriced; it is fairly priced for a business in the middle of a difficult transition, which is a much less exciting thing to say than either side wants to hear.